| 1 | [SID17514125] | Active | Potency | 3.9811 | qHTS Assay for Activators of ClpP [AID651965, Type: confirmatory] | ClpP [Bacillus subtilis] [gi:2668494] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Activators of ClpP | | AID | 651965 | | BioAssay type | confirmatory | | Target | ClpP [Bacillus subtilis] [gi:2668494] | | PubMed | | | Data Table |  |
|
| 2 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2113, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2113 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 3 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2113, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2113 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 4 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate [AID2113, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Human alpha-Glucosidase From Spleen Homogenate | | AID | 2113 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 5 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase [AID2115, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase | | AID | 2115 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 6 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase [AID2115, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase | | AID | 2115 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 7 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase [AID2115, Type: confirmatory] | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Purified Human alpha-Glucosidase | | AID | 2115 | | BioAssay type | confirmatory | | Target | lysosomal alpha-glucosidase preproprotein [Homo sapiens] [gi:119393891] | | PubMed | | | Data Table |  |
|
| 8 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Purified Human alpha-Galactosidase [AID2109, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Purified Human alpha-Galactosidase | | AID | 2109 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 9 | [SID17514125] | Active | Potency | 14.1254 | Confirmation of Inhibitors and Activators of Purified Human alpha-Galactosidase [AID2109, Type: confirmatory] | alpha-galactosidase [Homo sapiens] [gi:757912] |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | Potency | 14.1254 [uM] | | BioAssay | Confirmation of Inhibitors and Activators of Purified Human alpha-Galactosidase | | AID | 2109 | | BioAssay type | confirmatory | | Target | alpha-galactosidase [Homo sapiens] [gi:757912] | | PubMed | | | Data Table |  |
|
| 10 | [SID17514125] | Active | | | Counter screen assay of the parental HEK293 cells for compounds that activate the Choline Transporter (CHT) [AID623908, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Counter screen assay of the parental HEK293 cells for compounds that activate the Choline Transporter (CHT) | | AID | 623908 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 11 | [SID17514125] | Active | | | Counter screen assay of the parental HEK293 cells for compounds that activate the Choline Transporter (CHT) [AID623908, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Counter screen assay of the parental HEK293 cells for compounds that activate the Choline Transporter (CHT) | | AID | 623908 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 12 | [SID17514125] | Active | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 13 | [SID17514125] | Active | | | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) [AID488977, Type: screening] | SLC5A7 gene product [Homo sapiens] [gi:11141885] |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Primary cell-based screen for identification of compounds that allosterically activate the Choline Transporter (CHT) | | AID | 488977 | | BioAssay type | screening | | Target | SLC5A7 gene product [Homo sapiens] [gi:11141885] | | PubMed | | | Data Table |  |
|
| 14 | [SID17514125] | Active | | | Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2) [AID803, Type: screening] | Galanin receptor type 2 [gi:6016094] |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Primary cell-based high-throughput screening assay to identify agonists of Galanin Receptor 2 (GALR2) | | AID | 803 | | BioAssay type | screening | | Target | Galanin receptor type 2 [gi:6016094] | | PubMed | | | Data Table |  |
|
| 15 | [SID17514125] | Active | | | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. [AID2016, Type: screening] | MEP2 [Saccharomyces cerevisiae] [gi:1302091] |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Multiplex HTS Screen of TOR pathway GFP-fusion proteins in Saccharomyes cerevisiae_specifically_ MEP2_MLPCN. | | AID | 2016 | | BioAssay type | screening | | Target | MEP2 [Saccharomyces cerevisiae] [gi:1302091] | | PubMed | | | Data Table |  |
|
| 16 | [SID17514125] | Active | | | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex [AID2216, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Fluorescence Cell-Free Homogeneous Primary HTS to Identify Inhibitors of the RanGTP-Importin-beta complex | | AID | 2216 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID17514125] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID17514125] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 19 | [SID17514125] | Active | IC50 | | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. [AID1434, Type: confirmatory] | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Active | | IC50 | [uM] | | BioAssay | uHTS identification of compounds inhibiting the binding between the RUNX1 Runt domain and CBFb-SMMHC via a fluorescence resonance energy transfer (FRET) assay. | | AID | 1434 | | BioAssay type | confirmatory | | Target | core-binding factor subunit beta isoform 1 [Homo sapiens] [gi:13124881] | | PubMed | | | Data Table |  |
|
| 20 | [SID17514125] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 21 | [SID17514125] | Unspecified | Potency | | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate [AID624178, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Unspecified | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Human Acid Sphingomyelinase Assay: Native Substrate | | AID | 624178 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 22 | [SID17514125] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 23 | [SID17514125] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 24 | [SID17514125] | Unspecified | | | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening [AID488969, Type: screening] | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Unspecified | | BioAssay | Assay for HTS of Gi/Go-linked GPCRs using mGluR8: Primary Screening | | AID | 488969 | | BioAssay type | screening | | Target | metabotropic glutamate receptor 8 [Rattus norvegicus] [gi:1575471] | | PubMed | | | Data Table |  |
|
| 25 | [SID17514125] | Inactive | Potency | 3.9811 | qHTS Assay for Identification of Novel General Anesthetics [AID485281, Type: confirmatory] | Chain A, Horse Spleen Apoferritin [gi:254220970] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 3.9811 [uM] | | BioAssay | qHTS Assay for Identification of Novel General Anesthetics | | AID | 485281 | | BioAssay type | confirmatory | | Target | Chain A, Horse Spleen Apoferritin [gi:254220970] | | PubMed | | | Data Table |  |
|
| 26 | [SID17514125] | Inactive | Potency | 6.3096 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 27 | [SID17514125] | Inactive | Potency | 6.3096 | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS [AID504937, Type: confirmatory] | acid sphingomyelinase [Homo sapiens] [gi:179095] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 6.3096 [uM] | | BioAssay | Inhibitors of Secretory Acid Sphingomyelinase (S-ASM): qHTS | | AID | 504937 | | BioAssay type | confirmatory | | Target | acid sphingomyelinase [Homo sapiens] [gi:179095] | | PubMed | | | Data Table |  |
|
| 28 | [SID17514125] | Inactive | Potency | 22.3872 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 29 | [SID17514125] | Inactive | Potency | 22.3872 | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) [AID624417, Type: confirmatory] | glp-1 receptor [Homo sapiens] [gi:1724069] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 22.3872 [uM] | | BioAssay | qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode) | | AID | 624417 | | BioAssay type | confirmatory | | Target | glp-1 receptor [Homo sapiens] [gi:1724069] | | PubMed | | | Data Table |  |
|
| 30 | [SID17514125] | Inactive | Potency | 25.1189 | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS [AID624288, Type: confirmatory] | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 25.1189 [uM] | | BioAssay | qHTS for Antagonists of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS | | AID | 624288 | | BioAssay type | confirmatory | | Target | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short [gi:52000961] | | PubMed | | | Data Table |  |
|
| 31 | [SID17514125] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 32 | [SID17514125] | Inactive | Potency | 89.1251 | qHTS for Inhibitors of Polymerase Iota [AID588590, Type: confirmatory] | DNA polymerase iota [Homo sapiens] [gi:154350220] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | 89.1251 [uM] | | BioAssay | qHTS for Inhibitors of Polymerase Iota | | AID | 588590 | | BioAssay type | confirmatory | | Target | DNA polymerase iota [Homo sapiens] [gi:154350220] | | PubMed | | | Data Table |  |
|
| 33 | [SID17514125] | Inactive | | | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress [AID2732, Type: screening] | Ddit3 gene product [Mus musculus] [gi:160707929] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | HTS for small molecule inhibitors of CHOP to regulate the unfolded protein response to ER stress | | AID | 2732 | | BioAssay type | screening | | Target | Ddit3 gene product [Mus musculus] [gi:160707929] | | PubMed | | | Data Table |  |
|
| 34 | [SID17514125] | Inactive | | | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation [AID782, Type: screening] | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation | | AID | 782 | | BioAssay type | screening | | Target | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] | | PubMed | | | Data Table |  |
|
| 35 | [SID17514125] | Inactive | | | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation [AID782, Type: screening] | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | uHTS for Small Molecule Inhibitors of Eukaryotic Translation Initiation | | AID | 782 | | BioAssay type | screening | | Target | eukaryotic translation initiation factor 4E [Mus musculus] [gi:83627717] | | PubMed | | | Data Table |  |
|
| 36 | [SID17514125] | Inactive | | | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity [AID493131, Type: screening] | protein fosB [Mus musculus] [gi:6679827] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Activator for delta FosB/delta FosB homodimer Measured in Biochemical System Using Plate Reader - 2072-01_Activator_SinglePoint_HTS_Activity | | AID | 493131 | | BioAssay type | screening | | Target | protein fosB [Mus musculus] [gi:6679827] | | PubMed | | | Data Table |  |
|
| 37 | [SID17514125] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 38 | [SID17514125] | Inactive | | | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay [AID588413, Type: screening] | Gli1 [Mus musculus] [gi:6009644] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | uHTS identification of Gli-Sufu Antagonists in a luminescence reporter assay | | AID | 588413 | | BioAssay type | screening | | Target | Gli1 [Mus musculus] [gi:6009644] | | PubMed | | | Data Table |  |
|
| 39 | [SID17514125] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 40 | [SID17514125] | Inactive | | | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). [AID2098, Type: screening] | Hsf1 protein [Mus musculus] [gi:62740231] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Luminescence Cell-Based Primary HTS to Identify Inhibitors of Heat Shock Factor 1 (HSF1). | | AID | 2098 | | BioAssay type | screening | | Target | Hsf1 protein [Mus musculus] [gi:62740231] | | PubMed | | | Data Table |  |
|
| 41 | [SID17514125] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 42 | [SID17514125] | Inactive | | | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) [AID624169, Type: screening] | Htr2a gene product [Mus musculus] [gi:27753985] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Luminescence-based cell-based primary high throughput screening assay to identify agonists of the mouse 5-hydroxytryptamine (serotonin) receptor 2A (HTR2A) | | AID | 624169 | | BioAssay type | screening | | Target | Htr2a gene product [Mus musculus] [gi:27753985] | | PubMed | | | Data Table |  |
|
| 43 | [SID17514125] | Inactive | Potency | | qHTS of IL-2 Activators [AID652025, Type: confirmatory] | Il2 gene product [Mus musculus] [gi:7110653] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS of IL-2 Activators | | AID | 652025 | | BioAssay type | confirmatory | | Target | Il2 gene product [Mus musculus] [gi:7110653] | | PubMed | | | Data Table |  |
|
| 44 | [SID17514125] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 45 | [SID17514125] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 46 | [SID17514125] | Inactive | | | HTS for developing T Cell Immune Modulators [AID2052, Type: screening] | integrin alpha-L [Mus musculus] [gi:124486680] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | HTS for developing T Cell Immune Modulators | | AID | 2052 | | BioAssay type | screening | | Target | integrin alpha-L [Mus musculus] [gi:124486680] | | PubMed | | | Data Table |  |
|
| 47 | [SID17514125] | Inactive | | | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 [AID1672, Type: screening] | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Primary cell-based high-throughput screening assay for identification of compounds that inhibit/block inward-rectifying potassium ion channel Kir2.1 | | AID | 1672 | | BioAssay type | screening | | Target | inward rectifier potassium channel 2 [Mus musculus] [gi:6680530] | | PubMed | | | Data Table |  |
|
| 48 | [SID17514125] | Inactive | IC50 | | Fluorescence for the identification of compounds that decrease p/CIP protein stability [AID1984, Type: confirmatory] | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | IC50 | [uM] | | BioAssay | Fluorescence for the identification of compounds that decrease p/CIP protein stability | | AID | 1984 | | BioAssay type | confirmatory | | Target | nuclear receptor coactivator 3 [Mus musculus] [gi:118026946] | | PubMed | | | Data Table |  |
|
| 49 | [SID17514125] | Inactive | | | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex [AID504707, Type: screening] | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | BioAssay | Fluorescence polarization-based biochemical primary high throughput screening assay to identify activators of the Protein Kinase A-R1A (PKA-R1A) complex | | AID | 504707 | | BioAssay type | screening | | Target | cAMP-dependent protein kinase catalytic subunit beta isoform 1 [Mus musculus] [gi:6755076] | | PubMed | | | Data Table |  |
|
| 50 | [SID17514125] | Inactive | Potency | | qHTS for Inhibitors of Cell Surface uPA Generation [AID540303, Type: confirmatory] | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 17514125 | | CID | 5917798 | | Outcome | Inactive | | Potency | [uM] | | BioAssay | qHTS for Inhibitors of Cell Surface uPA Generation | | AID | 540303 | | BioAssay type | confirmatory | | Target | urokinase-type plasminogen activator [Mus musculus] [gi:6679377] | | PubMed | | | Data Table |  |
|